Is this you? Create Your Porfile
Avatar

James W. Janetka

Vertex Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where James W. Janetka is active.

Explore More

Publication

Featured researches published by James W. Janetka.

Archive | 2001

Pyrazole compositions useful as inhibitors of erk

Michael R. Hale; Xiaoling Xie; Jeremy Green; Jingrong Cao; Christopher T. Baker; Francois Maltais; James W. Janetka; Guy W. Bemis; Michael Mullican; Judith Straub; Qing Tang; Robert Mashal

Archive | 1999

Inhibitors of caspases

Marion W. Wannamaker; Guy W. Bemis; Paul S. Charifson; David J. Lauffer; Michael Mullican; Mark A. Murcko; Keith P. Wilson; James W. Janetka; Robert J. Davies; Anne-Laure Grillot; Zhan Shi; Cornelia J. Forster

Archive | 2002

Pyrazole-derived kinase inhibitors and uses thereof

Qing Tang; Francois Maltais; James W. Janetka; Michael R. Hale

Archive | 2001

Isoxazole compositions useful as inhibitors of ERK

Michael R. Hale; James W. Janetka; Francois Maltais; Jingrong Cao; Robert Mashal

Archive | 2001

Isoxazoles and their use as inhibitors of erk

Michael R. Hale; James W. Janetka; Francois Maltais; Jingrong Cao; Robert Mashal

Archive | 1999

Pentacyclic compounds useful as inhibitors of hepatitis c virus ns3 helicase

James W. Janetka; Brian Ledford; Michael Mullican

Archive | 2002

Inhibiteurs de kinase derives du pyrazole et leurs utilisations

Qing Tang; Francois Maltais; James W. Janetka; Michael R. Hale

Archive | 2002

Von pyrazol abgeleitete kinaseinhibitoren und deren verwendung From pyrazole derived kinase inhibitors and their use

Michael R. Hale; James W. Janetka; Francois Maltais; Qing Winchester Tang

Archive | 2001

Compositions de pyrazole utiles comme inhibiteurs de erk

Christopher T. Baker; Guy W. Bemis; Jingrong Cao; Jeremy Green; Michael R. Hale; James W. Janetka; Francois Maltais; Robert Mashall; Michael Mullican; Judith Straub; Qing Tang; Xiaoling Xie

Archive | 2001

Compositions de pyrazole utiles en tant qu'inhibiteurs d'erk

Michael R. Hale; James W. Janetka; Francois Maltais; Jingrong Cao

Explore More

Collaboration

Dive into the James W. Janetka's collaboration.

Top Co-Authors
Avatar

Francois Maltais

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Michael Mullican

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Michael R. Hale

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Guy W. Bemis

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Anne-Laure Grillot

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Jingrong Cao

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Keith P. Wilson

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Marion W. Wannamaker

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Mark A. Murcko

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Paul S. Charifson

Research Triangle Park

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge